Late-onset neutropenia following primary treatment of diff use large B-cell lymphoma with rituximab-containing therapy

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

(2011) Daniel Tesfa et al.   ARTHRITIS AND RHEUMATISM

Is Rituximab-induced Late-onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders?

(2011) Ian Hincks et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism

(2010) Szu-Chin Li et al.   AMERICAN JOURNAL OF HEMATOLOGY

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

(2009) Gillianne Geet Yi Lai et al.   AMERICAN JOURNAL OF HEMATOLOGY

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA

A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma

(2008) Arturo Molina   Annual Review of Medicine

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

(2008) Daniel Tesfa et al.   MEDICAL ONCOLOGY